RenovoRx

Business Services · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

2570 W El Camino Real Ste 320, Mountain ...

Phone Number

(650) 284-4433

Revenue

<$5 Million

Stock Symbol

RNXT

Industry

Business Services Manufacturing Pharmaceuticals Research & Development

About RenovoRx

RenovoRx, Inc. (Nasdaq: RNXT) is a targeted oncology company focused on developing and commercializing innovative local drug-delivery therapies for cancer. The companys FDA-cleared RenovoCath® catheter and patented Trans-Arterial Micro-Perfusion (TAMP) platform are designed to deliver therapeutics directly through the arterial wall to bathe tumors at the disease site, with the goal of improving efficacy while reducing systemic toxicity compared to traditional IV therapies. RenovoRx aims to transform cancer care by enabling safer, more precise delivery of diagnostic and therapeutic agents to patients with high unmet medical needs.Explore more
RenovoRx's Social MediaSIC Code 38,384NAICS Code 54,541Ticker NASDAQ: RNXTShow more

RenovoRx Org Chart

Shaun Bagai, Chief Executive Officer at RenovoRx
United States flag for contact location.

Chief Executive Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
Ramtin Agah, Chief Medical Officer & Founder at RenovoRx
United States flag for contact location.

Chief Medical Officer & Founder

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
JO
United States flag for contact location.

Clinical Research Associate

PhoneEmail
HM
United States flag for contact location.

Clinical Education Specialist

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to RenovoRx

Compare insights from companies similar to RenovoRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

RenovoRx

<$5M
11-50
Public
$27.2M
2009
$7.5M
11-50
Private
$84.3M
2005
JT
James TollController
$5M
11-50
Private
$27.1M
2016
AN
Aleksandar NacevChief Science Officer
<$5M
11-50
Private
$114.2M
2012
Richard Dorshow, Chief Scientific Officer, President, Co-founder at MediBeacon
Richard DorshowChief Scientific Officer, President, Co-founder
<$5M
11-50
Private
$6.4M
2016
JK
Jason KrohChief Technology Officer
Illustration of an envelope

RenovoRx Tech Stack

A closer look at the technologies used by RenovoRx

Top Business Services Companies

Frequently Asked Questions Regarding RenovoRx

What is RenovoRx's stock symbol?
RenovoRx's stock symbol is RNXT
What is RenovoRx's official website?
RenovoRx's official website is www.renovorx.com
What is RenovoRx's Revenue?
RenovoRx's revenue is <$5 Million
What is RenovoRx's SIC code?
RenovoRx's SIC: 38,384
What is RenovoRx's NAICS code?
RenovoRx's NAICS: 54,541
How many employees does RenovoRx have?
RenovoRx has 11-50 employees
What industry does RenovoRx belong to?
RenovoRx is in the industry of: Business Services, Manufacturing, Pharmaceuticals
What is RenovoRx competition?
RenovoRx top competitors include: Promaxo, MediBeacon, Strados Labs, Procyrion
What technology does RenovoRx use?
Some of the popular technologies that RenovoRx uses are: WordPress.org, PHP, Cloudflare Website Optimization, MySQL
How do I contact RenovoRx?
RenovoRx contact info: Phone number: (650) 284-4433 Website: www.renovorx.com
What does RenovoRx do?

RenovoRx, Inc. (Nasdaq: RNXT) is a targeted oncology company focused on developing and commercializing innovative local drug-delivery therapies for cancer. The companys FDA-cleared RenovoCath® catheter and patented Trans-Arterial Micro-Perfusion (TAMP) platform are designed to deliver therapeutics directly through the arterial wall to bathe tumors... at the disease site, with the goal of improving efficacy while reducing systemic toxicity compared to traditional IV therapies. RenovoRx aims to transform cancer care by enabling safer, more precise delivery of diagnostic and therapeutic agents to patients with high unmet medical needs.Read More

What are RenovoRx social media links?
RenovoRx Linkedin page RenovoRx Twitter page RenovoRx Facebook page
Who invested in RenovoRx?
RenovoRx has 20 investors including The Halo Fund, The Angels' Forum, Golden Seeds and Sand Hill Angels.
Is RenovoRx a public company?
Yes, RenovoRx is a public company and is traded under the symbol RNXT
See more information about RenovoRx

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.